Using a 3-O-sulfated heparin octasaccharide to inhibit the entry of herpes simplex virus type 1
Using a 3-O-sulfated heparin octasaccharide to inhibit the entry of herpes simplex virus type 1
复制标题
DOI:
10.1021/bi800205t
复制
发表时间:
2008-05-27
期刊:
影响因子:
2.9
通讯作者:
Liu, Jian
中科院分区:
文献类型:
--
作者:
Copeland, Ronald;Balasubramaniam, Arun;Liu, Jian
Heparan sulfate (HS) is a highly sulfated polysaccharide and is present in large quantities on the cell surface and in the extracellular matrix. Herpes simplex virus type 1 (HSV-1) utilizes a specialized cell surface HS, known as 3-O-sulfated HS, as an entry receptor to establish infection. Here, we exploit an approach to inhibiting HSV-1 infection by using a 3-O-sulfated octasaccharide, mimicking the active domain of the entry receptor. The 3-O-sulfated octasaccharide was synthesized by incubating a heparin octasaccharide (3-OH octasaccharide) with HS 3-O-sulfotransferase isoform 3. The resultant 3-O-sulfated octasaccharide has a structure of Delta UA2S-GleNS6S-IdoUA2S-GIcNS6S-IdoUA2S-GIcNS3S6S-IdoUA2S-GIcNS6S (where Delta UA is 4-deoxy-alpha-L-threo-hex-4-enopyranosyluronic acid, GlcN is D-glucosamine, and IdoUA is L-iduronic acid). Results from cell-based assays revealed that the 3-O-sulfated octasaccharide has stronger activity in blocking HSV-1 infection than that of the 3-OH octasaccharide, suggesting that the inhibition of HSV-1 infection requires a unique sulfation moiety. Our results suggest the feasibility of inhibiting HSV-1 infection by blocking viral entry with a specific oligosaccharide.